NEW YORK (GenomeWeb) – AITbiotech this week announced that its multiplexed real-time PCR test kit for Dengue virus has received a CE-IVD mark.
The abTes Den 4 qPCR I Kit can detect and differentiate Dengue virus serotypes 1, 2, 3, and 4 in a single reaction tube. The kit is designed for rapid diagnosis in clinical samples as well as for use in population surveillance, the firm said in a statement.
The abTes Den 4 pPCR I kit has "already been clinically validated as the preferred molecular assay for Dengue surveillance in several public health institutes" in Southeast Asia, and with CE-IVD marking, it can be offered in more regions, AITbiotech CEO Alex Thian said in a statement. He added that the firm is also in the process of seeking certification for several other multiplex diagnostic assays to expand its menu of tests offered in Asia.
In 2014, Singapore-based AITbiotech signed a distribution deal for its molecular assays in the Asia-Pacific region with Becton Dickinson.